Black Diamond Therapeutics
BDTX
BDTX
93 hedge funds and large institutions have $95.8M invested in Black Diamond Therapeutics in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
11% more funds holding
Funds holding: 84 → 93 (+9)
4.01% less ownership
Funds ownership: 71.92% → 67.91% (-4%)
Holders
93
Holding in Top 10
–
Calls
$61K
Puts
$9K
Top Buyers
| 1 | +$1.42M | |
| 2 | +$638K | |
| 3 | +$463K | |
| 4 |
Jane Street
New York
|
+$402K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$358K |
Top Sellers
| 1 | -$4.59M | |
| 2 | -$3.33M | |
| 3 | -$1.26M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$906K |
| 5 |
Morgan Stanley
New York
|
-$644K |